Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07294118 · ClinicalTrials.gov registry record · Phase 2
Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage
A Phase 2 study of Opioid Use and Headache, sponsored by The University of Texas Medical Branch, Galveston.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT07294118 is a Phase 2 study of Opioid Use and Headache that is actively recruiting participants, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 15 participants, below the 148,260-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07294118, a Phase 2 study of Opioid Use and Headache, is actively recruiting participants, sponsored by The University of Texas Medical Branch, Galveston.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if an infusion of lidocaine, with or without steroids, into the middle meningeal artery (MMA) helps relieve severe headaches in patients with spontaneous subarachnoid hemorrhage (SAH). It will also study the safety of this treatment.
Conditions Studied
Interventions
- DRUG Lidocaine
- DRUG Lidocaine and Dexamethasone
Study Locations (1)
Texas
- University of Texas Medical Branch, Galveston - Galveston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2026-01-02 |
| Est. Completion | 2027-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07294118
The ClinicalTrials.gov registry entry for NCT07294118 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 148,260-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Opioid Use appearing as the primary indexed condition, and to 2 interventions - of which Lidocaine is the first listed.
NCT07294118 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT07294118 about?
NCT07294118 is a clinical study titled "Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage". The goal of this clinical trial is to learn if an infusion of lidocaine, with or without steroids, into the middle meningeal artery (MMA) helps relieve severe headaches in patients with spontaneous subarachnoid hemorrhage (SAH). It will also study the safety of this treatment.
What is the current status of trial NCT07294118?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2026-01-02. Estimated completion is 2027-08.
What conditions does trial NCT07294118 study?
This clinical trial studies the following conditions: Opioid Use, Headache, Opiate Dependence, Subarachnoid Hemorrhage, Aneurysmal.
What interventions are being tested in trial NCT07294118?
The interventions under investigation include: Lidocaine (DRUG), Lidocaine and Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT07294118?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07294118 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal
RECRUITING · Phase 2
-
Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder Subjects
RECRUITING · Phase 2
-
Testosterone Replacement to Alleviate Pain in Postmenopausal Women (TRAPP Trial)
ACTIVE NOT RECRUITING · Phase 2
-
Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure
ACTIVE NOT RECRUITING · Phase 2
-
Managing Opioid Related Sleep Apnea With Acetazolamide
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.